Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)
Clinical trial NCT06195137 · COMPLETED
Trial details
- NCT number
- NCT06195137
- Sponsor
- Lu Jiang
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-13
- Primary completion
- 2023-06-15
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.